Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.38 |
| ▸ | TSPO | P30536 | 1/20 | 0.38 |
| ▸ | RORC | P51449 | 7/20 | 0.37 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.34 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22454887 | 1.00 | PTGER4 (0.39) | PTGER4GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL22017018 | 1.00 | PTGER4 (0.39) | PTGER4GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL22454880 | 1.00 | PTGER4 (0.39) | PTGER4GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL22016998 | 1.00 | PTGER4 (0.39) | PTGER4GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL24509883 | 0.92 | ATM (0.45) | PTGER4RORCARMEN1KMT2A | |
| SCHEMBL24509806 | 0.92 | ATM (0.45) | PTGER4RORCARMEN1KMT2A | |
| SCHEMBL24509797 | 0.92 | ATM (0.45) | PTGER4RORCARMEN1KMT2A | |
| SCHEMBL22458153 | 0.92 | ATM (0.45) | PTGER4RORCARMEN1KMT2A | |
| SCHEMBL22016732 | 0.92 | TSPO (0.38) | PTGER4GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL22017000 | 0.92 | TSPO (0.38) | PTGER4GABRA1GABRG2GABRB3GABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200161562-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200161562-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | EML4, CELF2, L1CAM | PTGER4 2489/4885GABRA1 1926/4885GABRG2 2763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.